Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regulators should better leverage effectiveness standards to enhance drug value.
Naci H, Alexander GC. Naci H, et al. Pharmacotherapy. 2014 Oct;34(10):1005-11. doi: 10.1002/phar.1467. Epub 2014 Jul 19. Pharmacotherapy. 2014. PMID: 25041851 Review.
Comparative fertility and pregnancy outcomes after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE group.
Athanasiou A, Veroniki AA, Efthimiou O, Kalliala I, Naci H, Bowden S, Paraskevaidi M, Martin-Hirsch P, Bennett P, Paraskevaidis E, Salanti G, Kyrgiou M. Athanasiou A, et al. Among authors: naci h. BMJ Open. 2019 Oct 21;9(10):e028009. doi: 10.1136/bmjopen-2018-028009. BMJ Open. 2019. PMID: 31636110 Free PMC article.
Evidence of comparative efficacy should have a formal role in European drug approvals.
Sorenson C, Naci H, Cylus J, Mossialos E. Sorenson C, et al. Among authors: naci h. BMJ. 2011 Sep 6;343:d4849. doi: 10.1136/bmj.d4849. BMJ. 2011. PMID: 21896610 No abstract available.
Raising the bar for market authorisation of new drugs.
Naci H, Cylus J, Vandoros S, Sato A, Perampaladas K. Naci H, et al. BMJ. 2012 Aug 7;345:e4261. doi: 10.1136/bmj.e4261. BMJ. 2012. PMID: 22872693 No abstract available.
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.
Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE. Naci H, et al. Eur J Prev Cardiol. 2013 Aug;20(4):641-57. doi: 10.1177/2047487313480435. Epub 2013 Feb 27. Eur J Prev Cardiol. 2013. PMID: 23447425 Review.
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials.
Naci H, Brugts JJ, Fleurence R, Ades AE. Naci H, et al. Eur J Prev Cardiol. 2013 Aug;20(4):658-70. doi: 10.1177/2047487313483600. Epub 2013 Mar 25. Eur J Prev Cardiol. 2013. PMID: 23529608 Review.
Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence?
Mossialos E, Naci H, Courtin E. Mossialos E, et al. Among authors: naci h. Health Policy. 2013 Jul;111(2):135-48. doi: 10.1016/j.healthpol.2013.04.003. Epub 2013 May 23. Health Policy. 2013. PMID: 23706523 Review.
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Naci H, Brugts J, Ades T. Naci H, et al. Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):390-9. doi: 10.1161/CIRCOUTCOMES.111.000071. Epub 2013 Jul 9. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23838105 Review.
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.
Naci H, Ioannidis JP. Naci H, et al. BMJ. 2013 Oct 1;347:f5577. doi: 10.1136/bmj.f5577. BMJ. 2013. PMID: 24473061 Free PMC article. Review.
How good is "evidence" from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs?
Naci H, Ioannidis JP. Naci H, et al. Annu Rev Pharmacol Toxicol. 2015;55:169-89. doi: 10.1146/annurev-pharmtox-010814-124614. Epub 2014 Aug 21. Annu Rev Pharmacol Toxicol. 2015. PMID: 25149917
95 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page